Strides to acquire PediaCare from Moberg Pharma

Brand acquisition to strengthen Consumer Health Care portfolio


Strides Shasun Limited announced that its wholly owned subsidiary Strides Arcolab International Limited, UK has entered into an agreement with Moberg Pharma, Sweden to acquire the ‘PediaCare' brand for a total consideration of USD5 million plus inventory value at closing.

PediaCare is an established paediatric cough, cold and allergy brand with annual sales of approximately USD6 Million. PediaCare will form an important part of Strides expanding consumer health care portfolio and brings with it expertise in the paediatric segment as well as a strong brand name with global potential.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email